Professor David Paterson
- Infectious Diseases Physician, Royal Brisbane and Women’s Hospital
- Director, The University of Queensland Centre for Clinical Research
Professor Paterson is a Consultant Infectious Diseases Physician at the Royal Brisbane and Women’s Hospital (RBWH). He is also Director at The University of Queensland Centre for Clinical Research (UQCCR). He is Australia’s most cited Infectious Diseases Physician and the country’s highest cited researcher in the field of Microbiology. He has been in the ISI Thomson Reuters Highly Cited List annually from 2015 to 2019.
Professor Paterson received his medical degree and PhD from The University of Queensland. His research focuses on the molecular and clinical epidemiology of infections with antibiotic resistant organisms, with the intent of translation of knowledge into optimal prevention and treatment of these infections. He has added clinical trials to his research portfolio and has recently conducted the world’s largest trial on antibiotics for extended-spectrum beta-lactamase producing bacterial infections (the “MERINO trial”). Professor Paterson has received research funding from the Centers for Disease Control and Prevention (CDC), Australia’s National Health and Medical Research Council (NHMRC) and the Medical Research Future Fund.
In 2007, Professor Paterson returned to Brisbane after ten years at The University of Pittsburgh School of Medicine. A 2008 Frank Fenner Award for Advanced Research in Infectious Diseases by the Australasian Society for Infectious Diseases (ASID) quickly followed and in 2009 he was awarded a Queensland Health Senior Clinical Research Fellowship and subsequently two NHMRC Practitioner Fellowships. He is now an NHMRC Investigator Grant holder.
Professor Jason Roberts
- Pharmacist Consultant HP6, Royal Brisbane and Women’s Hospital
- Professor, Schools of Medicine and Pharmacy, The University of Queensland
- Practitioner Fellow, National Health and Medical Research Council
Professor Jason Roberts has been a Pharmacist Consultant at the Royal Brisbane and Women’s Hospital (RBWH) since 2003. He has also been a National Health and Medical Research Council (NHMRC) Practitioner Fellow and Professor of Medicine and Pharmacy at The University of Queensland (UQ) since 2014. Professor Roberts has worked continuously as a clinical pharmacist, including during his PhD, which was under NHMRC scholarship funding. During his time at RBWH and UQ, Professor Roberts has established many collaborations with partners in healthcare, academic and industry enabling him to develop into a world-leading clinician-scientist supported by continual NHMRC funding, as well as Training Research (2009-12), Career Development (2013-16) and Practitioner (2017-21) Fellowships.
Professor Roberts was recognised as Australia’s leading researcher in two separate categories, Critical Care and Communicable Diseases, by the Australian’s 2019 Research Magazine. In 2015, he won the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Young Investigator Award for Research in Clinical Microbiology and Infectious Diseases. He was also given the Australian Clinical Pharmacist of the Year Award (Society of Hospital Pharmacists of Australia) in 2012.
Professor Roberts’ current research seeks to improve the accuracy of antibiotic dosing leading to improved treatment of infections. His strong and successful collaborative industry relationships also result in optimised dosing of new compounds. He has more than 400 career publications, has raised over $30 million in grant funding and has successfully supervised more than 10 students to receive a research higher degree, of which several have since been awarded competitive fellowships.
Professor Kevin B. Laupland
- Director of Research and Senior Medical Officer, Department of Intensive Care Medicine, Royal Brisbane and Women’s Hospital
- Professor, Queensland University of Technology
- Adjunct Professor, University of Calgary, Canada
Professor Laupland received his medical degree (Honours) from the University of Toronto then completed subsequent training in Calgary, Canada. He is certified in Internal Medicine, Infectious Diseases, and Critical Care Medicine by the Royal College of Physicians and Surgeons of Canada and holds a Masters of Science in Epidemiology. During 2002-2013, Professor Laupland was faculty appointed at the University of Calgary where he practiced both as an Intensivist and Infectious Diseases Consultant and led a highly productive multidisciplinary research program with a focus related to severe infections. In 2013 he moved to the Royal Inland Hospital in Kamloops, Canada where he continued his two clinical practices and led a transformation of medical services as Head of the Department of Medicine and subsequently as President of the Medical Staff.
In May 2019, Professor Laupland relocated to Brisbane to assume his new role as Professor, Intensivist, and Director of Intensive Care Research at the Royal Brisbane and Women’s Hospital (RBWH) and Queensland University of Technology (QUT).
Professor Laupland has made major contributions to the disciplines of epidemiology, infectious diseases and microbiology, and critical care medicine. While researching within a focus of severe infectious diseases, related to his clinical practices, his work has benefited from interdisciplinary and international collaboration across a broad range of specialities and study designs.
Professor Laupland is Co-Founder and Leader of the International Surveillance Collaborative (with centres in Australia, Canada, Denmark, Finland, the United Kingdom, and Sweden) which has published some of the largest and highest quality publications on the epidemiology of bloodstream infections to date. He has challenged the routine treatment practice of fever in ICU patients by conducting studies defining the determinants and outcomes of temperature regulation in the critically ill.
Professor Laupland is a proponent of the use of population-based designs and has demonstrated the value of these studies in determining the epidemiology of infectious diseases and critical care.
Professor Jeffrey Lipman
- Professor and Head, Mayne Academy of Critical Care, The University of Queensland
- Research Ambassador, Royal Brisbane and Women’s Hospital
- Senior Specialist, Intensive Care Services, Royal Brisbane and Women’s Hospital
- Scientific Consultant, Nimes University Hospital, University of Montpellier, France
- Adjunct Professor, Faculty of Health, Queensland University of Technology
- Adjunct Professor, The George Institute for Global Health, University of New South Wales
- Adjunct Professor, Chinese University of Hong Kong, China
- Honorary Professorial Research Fellow, University of the Witwatersrand, South Africa
Professor Lipman has qualifications in Anaesthesia and Intensive Care. Before coming to Australia in 1997, he established and was in charge of a number of Intensive Care and Trauma Units in South Africa.
For 22 years, Professor Lipman was Director of the Intensive Care Unit at Royal Brisbane and Women’s Hospital (RBWH). He also has been Director of a large multidisciplinary University research team with an output of more than 120 peer-reviewed articles per annum. Professor Lipman has been instrumental in developing the anaesthesiology and critical care component of a graduate medical program for Queensland and continues to lecture to medical and postgraduate students.
Professor Lipman’s research interests include all aspects of infection management in intensive care and he has a special interest in the pharmacokinetics of antibiotic dosage, an area in which he received his MD in 2006. Professor Lipman’s research into antibiotic usage in acute situations has received international recognition and he is regarded as an expert in the field. As such, Professor Lipman and his research team have conducted and presently conduct a number of clinical trials in Australia, New Zealand, Hong Kong, Europe and the UK.
Professor Lipman is an editorial board member for 10 international journals, reviews for 23 journals, is an external reviewer for National Health and Medical Research Council project grants and serves on the grant review committee.
Professor Michael Reade
- Australian Defence Force Professor of Military Medicine and Surgery, Faculty of Medicine, University of Queensland and ADF Joint Health Command
- Assistant Surgeon, General & Director General Health Reserve, Australian Army
- Honorary Staff Specialist Intensive Care Physician (“Pre-eminent” status – highest grade in Qld Health), Royal Brisbane and Women’s Hospital
Professor Reade is a practising specialist intensive care physician, anaesthetist and clinician scientist in the Australian Defence Force (ADF), seconded by the Joint Health Command to the University of Queensland to lead a program of research relevant to military trauma medicine and surgery, and to guide the implementation of modern trauma care into ADF practice.
Professor Reade trained in Clinical Anaesthetics and Intensive Care medicine at Royal North Shore Hospital (Sydney, Australia), the Austin Hospital (Melbourne, Australia), the John Radcliffe Hospital (Oxford, UK) and the University of Pittsburgh Medical Center (US). His Oxford PhD examined the molecular pathogenesis of septic shock, while his postdoctoral research fellowship focused on clinical trials and the analysis of large observational datasets.
Since 2012, Professor Reade has been the formal professional mentor for hospital specialist medical trainees in the fulltime Medical Specialist Program. In December 2018 he was appointed the Assistant Surgeon General – Army, responsible for technical regulation of all clinical personnel providing specialist medical, nursing and allied health support to the Australian Army.
Professor Reade’s research expertise is in large phase II / III clinical trials and in the analysis of observational data, including geospatial modelling. Applications of these techniques focus on fluid resuscitation and coagulopathy in trauma, blood transfusion, acute cognitive dysfunction in critical illness, and the design of trauma systems.
Professor Reade leads a collaboration of 19 co-investigators from the Australian Red Cross Lifeblood, the Australian & New Zealand Society of Cardiac & Thoracic Surgeons, the Australian & New Zealand Intensive Care Society, the Australian & New Zealand College of Anaesthetists, and the Transfusion Research Unit of Monash University.
Dr Shane Townsend
- Clinical Director, Royal Brisbane and Women’s Hospital
- Senior Lecturer, School of Medicine, University of Queensland
Dr Townsend is a graduate of the University of Queensland Medical School. He dual trained in Anaesthesia and Intensive Care. Dr Townsend has worked in the public and private sectors in Queensland and Victoria. His appointments as an intensive care specialist have included The Prince Charles Hospital, Royal Melbourne Hospital and the Mater Hospital.
Dr Townsend completed an Executive MBA through the Queensland University of Technology (QUT) in 2012 and was Director of the Intensive Care Units at Mater Health from 2010 to April 2018. In April 2018, Dr Townsend assumed the Directorship of the Royal Brisbane and Women’s Hospital (RBWH) Intensive Care Unit. He has been a Primary Examiner for the College of Intensive Care Medicine since 2007 and is a member of the Qld Regional Committee of the College.
Dr Andrew Redmond
- Infectious Diseases Physician, Royal Brisbane and Women’s Hospital